Gilead Ruling Signals That Innovating Can Lead To Liability

By Gary Myers · February 6, 2024, 5:15 PM EST

The Court of Appeal of the State of California ruled last month that a drug manufacturer can be liable for negligence for its delay in introducing an improved version of its...

To view the full article, register now.

Featured Stories

Courts Rule On Provider Self-Referrals, FCA Deal And More No Photo Available

Law360 Healthcare Authority looks at a split decision by Pennsylvania's highest court concerning a state prohibition on provider self-... (more story)

NJ Bill Supporting Abortion, Gender Care Hits Speed Bump No Photo Available

New Jersey legislation that would make it a crime to interfere with abortion hit a First Amendment snag last week as it neared passage... (more story)

Capital Markets Attys See Steady Momentum For Biotech IPOs No Photo Available

Attorneys that helped guide this year’s string of biotech IPOs expect the fast pace of public offerings to continue.